Browsing by Subject "osteosarcoma"
Now showing items 1-4 of 4
-
(2011-08-08)A novel Y-90 liquid brachytherapy strategy is currently being studied for the treatment of osteosarcoma using a preclinical translational model in dogs to assess its potential efficacy and toxicity. In this study, dosimetry ...
-
(2019-11-29)Extracellular matrix (ECM) is a primary component of the osteogenic microenvironment, providing support for attachment, proliferation, and differentiation to facilitate bone growth and maintenance. Previously we have shown ...
-
(2014-04-24)Osterix is a transcription factor that is essential for osteoblast differentiation and periostin is a matricellular protein that, in the jaw bones, is expressed in the periosteum and periodontal ligament (PDL). It has been ...
-
(2023-01-18)Osteosarcoma (OS) is the most common bone tumor in the pediatric population, representing >50% of bone malignancies in patients <20 years old. Following surgical resection of the tumor, allografts or metal endoprostheses ...